Quick Takeaways
- This page summarizes Jack E. Stover's Form 3 filing for Transcode Therapeutics, Inc. (RNAZ).
- 0 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 22 Dec 2025, 16:39.
Jack E. Stover - 19 Dec 2025 Form 3 Insider Report for Transcode Therapeutics, Inc. (RNAZ)
- Role
- Director
- Signature
- /s/ Thomas A. Fitzgerald, Attorney-in-Fact
- Issuer symbol
- RNAZ
- Transactions as of
- 19 Dec 2025
- Net transactions value
- $0
- Form type
- 3
- Filing time
- 22 Dec 2025, 16:39:09 UTC
- Previous filing
- 16 Dec 2025
- Next filing
- 30 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Jack E. Stover filed Form 3 for Transcode Therapeutics, Inc. (RNAZ) on 22 Dec 2025."
What Changed
- Previous filing in this sequence was filed on 16 Dec 2025.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Official SEC Source
See Original Filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| STOVER JACK E | Director | C/O TRANSCODE THERAPEUTICS, INC., 6 LIBERTY SQUARE, #2382, BOSTON | /s/ Thomas A. Fitzgerald, Attorney-in-Fact | 22 Dec 2025 | 0001203603 |
No securities are beneficially owned.
Remarks:
Exhibit 24: Power of Attorney